These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29522880)

  • 41. MECHANISMS OF RESISTANCE TO CIPROFLOXACIN AND GENETIC DIVERSITY OF ESCHERICHIA COLI STRAINS ORIGINATING FROM URINE CULTURES PERFORMED FOR ROMANIAN ADULTS.
    Cristea VC; Oprea M; Neacşu G; Gîlcă R; Popa MI; Usein CR
    Roum Arch Microbiol Immunol; 2015; 74(3-4):73-8. PubMed ID: 27328520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alteration of the intracellular concentration of aminoacyl-tRNA synthetases and isoaccepting tRNAs during amino-acid limited growth in Escherichia coli.
    Thomale J; Nass G
    Eur J Biochem; 1978 Apr; 85(2):407-18. PubMed ID: 348470
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Deciphering molecular mechanism of silver by integrated omic approaches enables enhancing its antimicrobial efficacy in E. coli.
    Wang H; Yan A; Liu Z; Yang X; Xu Z; Wang Y; Wang R; Koohi-Moghadam M; Hu L; Xia W; Tang H; Wang Y; Li H; Sun H
    PLoS Biol; 2019 Jun; 17(6):e3000292. PubMed ID: 31181061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outer membrane proteomics of kanamycin-resistant Escherichia coli identified MipA as a novel antibiotic resistance-related protein.
    Li H; Zhang DF; Lin XM; Peng XX
    FEMS Microbiol Lett; 2015 Jun; 362(11):. PubMed ID: 25940639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nontargeted Metabolomics Reveals the Multilevel Response to Antibiotic Perturbations.
    Zampieri M; Zimmermann M; Claassen M; Sauer U
    Cell Rep; 2017 May; 19(6):1214-1228. PubMed ID: 28494870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The comparison of MAMA PCR and SSCP PCR to study chromosomal resistance against Ciprofloxacin and Nalidixic acid in Escherichia coli and Klebsiella pneumoniae.
    Hashemi B; Abdollahi M; Rafiei A; Pormohammad A; Ahanjan M; Moghadaszadeh M; Rashidian S
    Microb Pathog; 2018 Jul; 120():181-186. PubMed ID: 29742463
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanisms of action of and resistance to ciprofloxacin.
    Hooper DC; Wolfson JS; Ng EY; Swartz MN
    Am J Med; 1987 Apr; 82(4A):12-20. PubMed ID: 3034057
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.
    Strahilevitz J; Hooper DC
    Antimicrob Agents Chemother; 2005 May; 49(5):1949-56. PubMed ID: 15855518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resistance Pattern and Molecular Characterization of Enterotoxigenic Escherichia coli (ETEC) Strains Isolated in Bangladesh.
    Begum YA; Talukder KA; Azmi IJ; Shahnaij M; Sheikh A; Sharmin S; Svennerholm AM; Qadri F
    PLoS One; 2016; 11(7):e0157415. PubMed ID: 27428376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular analysis of ciprofloxacin resistance and clonal relatedness of clinical Escherichia coli isolates from haematology patients receiving ciprofloxacin prophylaxis.
    van Hees BC; Tersmette M; Willems RJ; de Jong B; Biesma D; van Hannen EJ
    J Antimicrob Chemother; 2011 Aug; 66(8):1739-44. PubMed ID: 21636586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
    Lee MY; Choi HJ; Choi JY; Song M; Song Y; Kim SW; Chang HH; Jung SI; Kim YS; Ki HK; Son JS; Kwon KT; Heo ST; Yeom JS; Shin SY; Chung DR; Peck KR; Song JH; Ko KS
    J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of a 3-hydroxypropionate resistant Escherichia coli strain.
    Liu M; Han X; Xian M; Ding Y; Liu H; Zhao G
    Bioengineered; 2016; 7(1):21-7. PubMed ID: 26709549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simulated microgravity affects ciprofloxacin susceptibility and expression of acrAB-tolC genes in E. coli ATCC25922.
    Xu B; Li C; Zheng Y; Si S; Shi Y; Huang Y; Zhang J; Cui Y; Cui Y
    Int J Clin Exp Pathol; 2015; 8(7):7945-52. PubMed ID: 26339360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gut Colonization of Healthy Children and Their Mothers With Pathogenic Ciprofloxacin-Resistant Escherichia coli.
    Gurnee EA; Ndao IM; Johnson JR; Johnston BD; Gonzalez MD; Burnham CA; Hall-Moore CM; McGhee JE; Mellmann A; Warner BB; Tarr PI
    J Infect Dis; 2015 Dec; 212(12):1862-8. PubMed ID: 25969564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proteomic analysis of nalidixic acid resistance in Escherichia coli: identification and functional characterization of OM proteins.
    Lin XM; Li H; Wang C; Peng XX
    J Proteome Res; 2008 Jun; 7(6):2399-405. PubMed ID: 18438992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective role of E. coli outer membrane vesicles against antibiotics.
    Kulkarni HM; Nagaraj R; Jagannadham MV
    Microbiol Res; 2015 Dec; 181():1-7. PubMed ID: 26640046
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli.
    Sreedharan S; Oram M; Jensen B; Peterson LR; Fisher LM
    J Bacteriol; 1990 Dec; 172(12):7260-2. PubMed ID: 2174869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chromosomally encoded gyrase inhibitor GyrI protects Escherichia coli against DNA-damaging agents.
    Chatterji M; Sengupta S; Nagaraja V
    Arch Microbiol; 2003 Nov; 180(5):339-46. PubMed ID: 13680098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.